Local News Astellas and Seagen Announce Submission of Two Supplemental Biologics License Applications to the FDA for PADCEV® in Locally Advanced or Metastatic Urothelial CancerBioSpace | February 22, 2021Astellas Pharma US (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen, Inc. (Nasdaq:SGEN) today…kchenFebruary 22, 2021 Read More
Local News Notch Therapeutics Raises $85M for Cancer Treatments and Plans to Open Seattle LocationGeekWire | February 22, 2021New funding: Notch Therapeutics has raised a $85 million Series A round, bringing its total funding to…kchenFebruary 22, 2021 Read More
Publications of the Week Targeting the Membrane-Proximal C2-Set Domain of CD33 for Improved CD33-Directed ImmunotherapyGodwin, C.D., et al. | February 22, 2021There is increasing interest in targeting CD33 in malignant and non-malignant disorders. In acute myeloid…kchenFebruary 22, 2021 Read More
Publications of the Week BRCA1/BARD1 Site-Specific Ubiquitylation of Nucleosomal H2A Is Directed by BARD1Witus, S.R., et al. | February 19, 2021Mutations in the E3 ubiquitin ligase RING domains of BRCA1/BARD1 predispose carriers to breast and…kchenFebruary 19, 2021 Read More